Claims Analysis
Total Claims: 18
Claim 1
Independent Claim
46 words
A 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula: ##STR4## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower hydroxy alkyl and Q is hydrogen or halo or a pharmaceutically-acceptable acid-addition salt thereof.
Claim 2
Dependent Claim
46 words
A 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula: ##STR4## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower hydroxy alkyl and Q is hydrogen or halo or a pharmaceutically-acceptable acid-addition salt thereof.
Claim 3
Dependent Claim
13 words
A compound according to claim 1 where R and Q are each hydrogen.
Claim 4
Dependent Claim
14 words
A compound according to claim 1 where Q is halo and R is hydrogen.
Claim 5
Dependent Claim
5 words
5-(4-Pyridinyl)-2(1H)-pyridinone according to claim 2.
Claim 6
Dependent Claim
5 words
3-Chloro-5-(4-pyridinyl)-2(1H)-pyridinone according to claim 3.
Claim 7
Dependent Claim
5 words
3-Bromo-5-(4-pyridinyl)-2(1H)-pyridinone according to claim 3.
Claim 8
Dependent Claim
66 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR5## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl and Q is hydrogen, or pharmaceutically-acceptable acid-addition salt thereof.
Claim 9
Dependent Claim
66 words
A cardiotonic composition for increasing cardiac contractility, said composition comprising a pharmaceutically-acceptable inert carrier and, as the active component thereof, an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridinone having the formula ##STR5## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl and Q is hydrogen, or pharmaceutically-acceptable acid-addition salt thereof.
Claim 10
Dependent Claim
12 words
A composition according to claim 7 where the active component is 5-(4-pyridinyl)-2(1H)-pyridinone.
Claim 11
Independent Claim
74 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering orally or parenterally in a solid or liquid dosage form to such patient an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridone having the formula ##STR6## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl and Q is hydrogen, or pharmaceutically-acceptable acid-addition salt thereof.
Claim 12
Independent Claim
74 words
The method for increasing cardiac contractility in a patient requiring such treatment which comprises administering orally or parenterally in a solid or liquid dosage form to such patient an effective amount of a cardiotonic 1-R-3-Q-5-PY-2(1H)-pyridone having the formula ##STR6## where PY is 4- or 3- or 2-pyridinyl or 4- or 3- or 2-pyridinyl having one or two lower-alkyl substituents, R is hydrogen, lower-alkyl or lower-hydroxyalkyl and Q is hydrogen, or pharmaceutically-acceptable acid-addition salt thereof.
Claim 13
Dependent Claim
11 words
The method according to claim 9 where the 1-R-3-Q-5-PY-2(1H)-pyridinone is 5-(4-pyridinyl)-2(1H)-pyridinone.
Claim 14
Dependent Claim
34 words
The process of preparing the compound of claim 1 where Q is halo and R is hydrogen which comprises reacting 5-PY-2(1H)-pyridinone with halogen to produce 3-halo-5-PY-2(1H)-pyridinone where PY is defined as in claim 1.
Claim 15
Dependent Claim
29 words
The process for preparing the compounds of claim 1 where Q is hydrogen which comprises reacting the corresponding compound where Q is carboxy or cyano with aqueous mineral acid.
Claim 16
Dependent Claim
20 words
The process according to claim 12 which comprises reacting 1,2-dihydro-2-oxo-5-(4-pyridinyl)-nicotinonitrile or 1,2-dihydro-2-oxo-5-(4-pyridinyl)-nicotinic acid with aqueous sulfuric acid to produce 5-(4-pyridinyl)-2(1H)-pyridinone.
Claim 17
Dependent Claim
41 words
The process for preparing the compound of claim 1 where Q is halo which comprises the steps of heating 1,2-dihydro-2-oxo-5-PY-nicotinonitrile or 1,2-dihydro-2-oxo-5-PY-nicotinic acid with an aqueous mineral acid to produce 5-PY-2(1H)-pyridinone and reacting 5-PY-2(1H)-pyridinone with halogen to produce the corresponding 3-halo-5-PY-2(1H)-pyridinone.
Claim 18
Dependent Claim
50 words
The process which comprises the steps of reacting 1-R-5-PY-2(1H)-pyridinone with halogen to produce the corresponding 1-R-3-halo-5-PY-2(1H)-pyridinone according to claim 1 and reacting said 3-halo compound with a lower-alkylamine or di-(lower-alkyl)amine, to produce the corresponding respective 3-(lower-alkylamino) or 3-[di-(lower-alkyl)amino] compound, where PY and R have the meanings given in claim 1.